Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs.

Abstract

Twenty-one dogs with idiopathic superficial recurrent pyoderma were entered into a double-blind, placebo-controlled study to evaluate the efficacy of a commercial staphylococcal bacterin. The study spanned an 18-week period. All dogs were administered sodium oxacillin orally for the initial 6 weeks of the study. Dogs were given the bacterin or placebo SC, twice weekly at 3- or 4-day intervals, beginning at week 0 and continuing for 18 weeks. Dogs given antibiotics plus the bacterin (n = 13) had a significantly (P less than 0.05) better treatment response than those given antibiotic plus placebo.

• Authors: D J DeBoer, K A Moriello, C B Thomas, K T Schultz
• Journal: American journal of veterinary research (Am J Vet Res) Vol. 51 Issue 4 Pg. 636-9 (Apr 1990) ISSN: 0002-9645 [Print] United States
• PMID: 2327626 (Publication Type: Journal Article)

Chemical References

• Staphylococcal Vaccines
• Oxacillin

Topics

• Animals
• Dog Diseases (drug therapy)
• Dogs
• Double-Blind Method
• Injections, Subcutaneous
• Oxacillin (therapeutic use)
• Pyoderma (drug therapy, veterinary)
• Recurrence
• Staphylococcal Vaccines (administration & dosage, therapeutic use)
• Time Factors